H Habehh, S Gohel - Current genomics, 2021 - ncbi.nlm.nih.gov
Abstract Recent advancements in Artificial Intelligence (AI) and Machine Learning (ML) technology have brought on substantial strides in predicting and identifying health …
ML Choi, A Chappard, BP Singh, C Maclachlan… - Nature …, 2022 - nature.com
Aggregation of alpha-synuclein (α-Syn) drives Parkinson's disease (PD), although the initial stages of self-assembly and structural conversion have not been directly observed inside …
Parkinson's Disease (PD) is a highly prevalent neurodegenerative disease among older adults. PD neuropathology is marked by the progressive loss of the dopaminergic neurons …
F Weiss, A Labrador-Garrido, N Dzamko… - Neurobiology of …, 2022 - Elsevier
Immune changes occur in all neurodegenerative conditions, but there are significant differences between diseases. For Parkinson's disease (PD), the immune system …
E Kip, LC Parr-Brownlie - Ageing Research Reviews, 2022 - Elsevier
Parkinson's disease (PD) is the second most common age-associated neurodegenerative disorder and is characterised by progressive loss of dopamine neurons in the substantia …
Parkinson's disease (PD) is a devastating neurological disease that cannot be identified with traditional plasma experiments, necessitating the development of a faster, less expensive …
NH Rashidah, SM Lim, CF Neoh, ABA Majeed… - Ageing research …, 2022 - Elsevier
This systematic review appraised previous findings on differential gut microbiota composition and intestinal permeability markers between frail and healthy older adults. A …
Systemic inflammation and mitochondrial dysfunction are involved in neurodegeneration in Parkinson's disease (PD). Extracellular vesicle (EV) trafficking may link inflammation and …
T Alsuliman, D Humaidan, L Sliman - Current research in translational …, 2020 - Elsevier
Motivation As a result of the worldwide health care system digitalization trend, the produced healthcare data is estimated to reach as much as 2314 Exabytes of new data generated in …